Heparin, Low-Molecular-Weight

subject area of

2 Mechanisms of action of low molecular weight heparins and heparinoids Academic Article
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer Academic Article
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 Academic Article
4 Clinical potential of low molecular weight heparins Academic Article
ISTH guidelines for antithrombotic treatment in COVID ‐19 Academic Article
A Comparison of General Anesthesia and Regional Anesthesia as a Risk Factor for Deep Vein Thrombosis Following Hip Surgery: A Critical Review Academic Article
A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation Academic Article
A Histomorphometric Comparison of the Effects of Heparin and Low-Molecular-Weight Heparin on Cancellous Bone in Rats Academic Article
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism Academic Article
A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients Academic Article
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
A review of the two major regulatory pathways for non-proprietary low-molecular-weight heparins Academic Article
A systematic review of economic analyses of low-molecular-weight heparin for the treatment of venous thromboembolism Academic Article
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies Academic Article
AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery - TREK: a dose-ranging study Academic Article
Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis Academic Article
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness Academic Article
Advances and contemporary issues in prophylaxis for deep vein thrombosis. Academic Article
Advances in the management of venous thromboembolism. Academic Article
Airways Disease Presenting as Restrictive Impairment: Response Academic Article
Alternatives to Low Molecular Weight Heparin for Anticoagulation in Pregnant Women with Mechanical Heart Valves in Middle-Income Countries: A Cohort Study Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients Academic Article
American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy Academic Article
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer Academic Article
An Approach to Assigning In Vitro Potency to Unfractionated and Low Molecular Weight Heparins Based on the Inhibition of Prothrombin Activation and Catalysis of Thrombin Inhibition Academic Article
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial Academic Article
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial Academic Article
An overview of clinical trials of low molecular weight heparin fractions. Academic Article
Angina (unstable). Academic Article
Angina (unstable). Academic Article
Angina (unstable). Academic Article
Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery Academic Article
Anticoagulant Mechanisms of Orgaran (Org 10172) and Its Fraction with High Affinity to Antithrombin III (Org 10849) Academic Article
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography Academic Article
Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency Academic Article
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis Academic Article
Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis Academic Article
Anticoagulant therapy in acute brain ischaemia Academic Article
Anticoagulants in acute coronary syndromes Academic Article
Anticoagulants in cancer Academic Article
Anticoagulation Therapy Academic Article
Anticoagulation Therapy in Children Academic Article
Anticoagulation and Bleeding: A Pooled Analysis of Lung Cancer Trials of the NCIC Clinical Trials Group Academic Article
Anticoagulation for patients with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for people with cancer and central venous catheters Academic Article
Anticoagulation for perioperative thromboprophylaxis in people with cancer Academic Article
Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters Academic Article
Anticoagulation therapy in patients with prosthetic heart valves. Academic Article
Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin Academic Article
Antithrombins: Their Potential as Antithrombotic Agents Academic Article
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
Antithrombotic Therapy in Children* Academic Article
Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin Academic Article
Antithrombotic Therapy in Neonates and Children Academic Article
Antithrombotic Therapy in Neonates and Children Academic Article
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents Academic Article
Antithrombotic therapy in children with venous thromboembolism Academic Article
Antithrombotic therapy: the expanding role of low molecular weight heparin. Academic Article
Antithrombotics and Anticoagulants in Coronary Syndromes and Stroke Academic Article
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery Academic Article
Ardeparin Sodium for Extended Out-of-Hospital Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement Academic Article
Are There Patients With Acute Ischemic Stroke and Atrial Fibrillation That Benefit From Low Molecular Weight Heparin? Academic Article
Aspirin Versus Low-Molecular-Weight Heparin for Ischemic Stroke in Children: An Unanswered Question Academic Article
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin Academic Article
Association between perioperative low-molecular-weight heparin vs unfractionated heparin and clinical outcomes in patients with cancer undergoing surgery Academic Article
Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey Academic Article
Barriers and facilitators to adopting high value practices and de-adopting low value practices in Canadian intensive care units: a multimethod study Academic Article
Benefit of Selective Factor Inhibition Academic Article
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials Academic Article
Beyond Heparin and Aspirin Academic Article
Beyond Unfractionated Heparin and Warfarin Academic Article
Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin Academic Article
Biologic rationale for the therapeutic role of specific antithrombins Academic Article
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures Academic Article
Bridging Anticoagulation Academic Article
Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation Academic Article
Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery Academic Article
Can we differentiate the low-molecular-weight heparins? Academic Article
Can we optimise treatment of thrombosis? Academic Article
Central venous catheters are an important factor in paediatric thrombosis Academic Article
Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management Academic Article
Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: The CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction Academic Article
Changing Paradigms in the Management of Venous Thromboembolism Academic Article
Characterization of Heparin Aerosols Generated in Jet and Ultrasonic Nebulizers Academic Article
Chills and limb pain following administration of low-molecular-weight heparin for treatment of acute venous thromboembolism Academic Article
Choice of low molecular weight heparins Academic Article
Choice of low molecular weight heparins. Academic Article
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy Academic Article
Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry1 Academic Article
Clinical potential of antithrombotic drugs in coronary syndromes Academic Article
Close Approximation of Two Platelet Factor 4 Tetramers by Charge Neutralization Forms the Antigens Recognized by HIT Antibodies Academic Article
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Academic Article
Comparative effects of heparin and LMW heparin on hemostasis Conference Paper
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance. Academic Article
Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry) Academic Article
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
Comparison of Fixed-Dose Weight-Adjusted Unfractionated Heparin and Low-Molecular-Weight Heparin for Acute Treatment of Venous Thromboembolism Academic Article
Comparison of pain and ecchymosis with low-molecular-weight heparin vs. unfractionated heparin in patients requiring bridging anticoagulation after warfarin interruption: a randomized trial Academic Article
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism Academic Article
Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Academic Article
Comparison of the relative efficacy and safety of low-molecular-weight heparin and unfractionated heparin for the treatment of venous thrombosis. Academic Article
Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism Academic Article
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Academic Article
DOACs vs LMWHs in hospitalized medical patients: a systematic review and meta-analysis that informed 2018 ASH guidelines Academic Article
Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol Academic Article
Decreased Concentrations of Heparinoids Are Required to Inhibit Thrombin Generation in Plasma from Newborns and Children Compared to Plasma from Adults due to Reduced Thrombin Potential Academic Article
Deep vein thrombosis: update on diagnosis and management Academic Article
Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis Academic Article
Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial Academic Article
Diagnosis and Anticoagulant Treatment Academic Article
Diagnosis and Treatment of Venous Thromboembolism Academic Article
Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation Academic Article
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis Academic Article
Distal deep vein thrombosis – a benign disease? Academic Article
Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin–sodium) in pediatric patients Academic Article
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events Academic Article
Dosing Frequency of Unfractionated Heparin Thromboprophylaxis Academic Article
ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events. Academic Article
Early Recovery and Functional Outcome are Related with Causal Stroke Subtype: Data from the Tinzaparin in Acute Ischemic Stroke Trial Academic Article
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis Academic Article
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review Academic Article
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Academic Article
Edoxaban is non-inferior to low-molecular-weight heparin for treating cancer-associated venous thromboembolism Academic Article
Effect of Nonspecific Binding to Plasma Proteins on the Antithrombin Activities of Unfractionated Heparin, Low-Molecular-Weight Heparin, and Dermatan Sulfate Academic Article
Effect of covalent antithrombin-heparin on activated protein C inactivation by protein C inhibitor Academic Article
Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro Academic Article
Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography Academic Article
Effects of Reviparin, a Low-Molecular-Weight Heparin, on Mortality, Reinfarction, and Strokes in Patients With Acute Myocardial Infarction Presenting With ST-Segment Elevation Academic Article
Effects of Unfractionated Heparin, Dermatan Sulfate and Low Molecular Weight Heparin on Vessel Wall Permeability in Rabbits Academic Article
Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty Academic Article
Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients Academic Article
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 Academic Article
Efficacy of a postoperative regimen of enoxaparin in deep vein thrombosis prophylaxis Academic Article
Emerging anticoagulants for the treatment of venous thromboembolism Academic Article
End of the road for heparin thromboprophylaxis Academic Article
Enoxaparin prophylaxis in elective hip surgery. Academic Article
Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization. Academic Article
Evaluating compliance of extended venous thromboembolism prophylaxis following abdominopelvic surgery for cancer: A multidisciplinary quality improvement project Academic Article
Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol Academic Article
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis Academic Article
Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates Academic Article
Evidence for the Needs of Out-of-Hospital Thrombosis Prophylaxis Academic Article
Ex-Vivo and In-Vitro Evidence that Low Molecular Weight Heparins Exhibit Less Binding to Plasma Proteins than Unfractionated Heparin Academic Article
Exercise-Induced Deep Vein Thrombosis of the Upper Extremity Academic Article
Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review Academic Article
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy? Academic Article
Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Academic Article
Extended venous thromboembolism prophylaxis in patients undergoing hip fracture surgery – the SAVE-HIP3 study Academic Article
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Academic Article
Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols Academic Article
Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty Academic Article
Fondaparinux in the management of patients with ST-elevation acute myocardial infarction Academic Article
From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE) Academic Article
From unfractionated heparins to low molecular weight heparins. Academic Article
Glycosaminoglycans Bind Factor Xa in a Ca²⁺-Dependent Fashion and Modulate Its Catalytic Activity Academic Article
Guide to Anticoagulant Therapy: Heparin Academic Article
Guide to Anticoagulant Therapy: Heparin Academic Article
Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association. Academic Article
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
Hemorrhagic Complications of Anticoagulant Treatment Academic Article
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Academic Article
Heparin Thromboprophylaxis in Medical-Surgical Critically Ill Patients Academic Article
Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss Academic Article
Heparin and Angiogenesis Academic Article
Heparin and Low Molecular Weight Heparins Inhibit Prothrombinase Formation but not its Activity in Plasma Academic Article
Heparin and Low-Molecular-Weight Heparin Academic Article
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety Academic Article
Heparin and Platelets Academic Article
Heparin and low molecular weight heparins as scaffolds for assembling antithrombin and serine proteases Academic Article
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
Heparin compromises streptokinase-induced arterial patency in rabbits Academic Article
Heparin sensitivity and resistance in the neonate: An explanation Academic Article
Heparin, Low Molecular Weight Heparin, and Heparin-Induced Thrombocytopenia in the ICU Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia Academic Article
Heparin-Induced Thrombocytopenia: Real-World Issues Academic Article
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention Academic Article
Heparin-induced thrombocytopenia and its treatment. Conference Paper
Heparin-induced thrombocytopenia: A stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings Academic Article
Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Academic Article
Heparins in sepsis-induced disseminated intravascular coagulation: Low weight—high impact?* Academic Article
High incidence of venous thromboembolism despite electronic alerts for thromboprophylaxis in hospitalised cancer patients Academic Article
Hirudin and thrombosis prophylaxis Academic Article
Home-treatment of deep vein thrombosis in patients with cancer. Academic Article
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy Academic Article
How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized? Academic Article
How to use low-molecular-weight heparin to treat neonatal thrombosis in clinical practice Academic Article
Impact of the patient population on the risk for heparin-induced thrombocytopenia Academic Article
Improving the adoption of optimal venous thromboembolism prophylaxis in critically ill patients: A process evaluation of a complex quality improvement initiative Academic Article
In high-risk patients with cancer, thromboprophylaxis with rivaroxaban did not reduce VTE events at 180 days Academic Article
In vitro and ex vivo Activities of CY216: Comparison with Other Low Molecular Weight Heparins Academic Article
Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study Conference Paper
Incidence of intracranial bleeding in anticoagulated patients with minor head injury: a systematic review and meta-analysis of prospective studies Academic Article
Induction of the Acute-Phase Reaction Increases Heparin-Binding Proteins in Plasma Academic Article
Inhibition of plasmin generation in plasma by heparin, low molecular weight heparin, and a covalent antithrombin–heparin complex Academic Article
Initial treatment of venous thromboembolism Academic Article
Interaction of low molecular weight heparin with ketorolac Academic Article
International Committee Communications. Standardization and clinical use of LMW heparin. Report of the ICTH Heparin Subcommittee, Brussels, July 1987. Academic Article
Investigations of the effectiveness of heparin variants as inhibitors of histones Academic Article
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin? Academic Article
LMW Heparin for Deep Vein Thrombosis Academic Article
Laboratory monitoring of low-molecular-weight heparin therapy Academic Article
Limitations of conventional treatment options for heparin-induced thrombocytopenia. Academic Article
Localization of heparin and low-molecular-weight heparin in the rat kidney Academic Article
Long-Term Prophylaxis in Venous Thromboembolism: LMWH or Oral Anticoagulation? Conference Paper
Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy Academic Article
Low Molecular Weight Heparin Academic Article
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
Low Molecular Weight Heparins (LMWH) in the Treatment of Patients with Acute Venous Thromboembolism Conference Paper
Low molecular weight heparin Academic Article
Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. Academic Article
Low molecular weight heparin and bleeding in patients with chronic renal failure Academic Article
Low molecular weight heparin and unfractionated heparin in the early pharmacologic management of acute coronary syndromes: a meta-analysis of randomized clinical trials. Academic Article
Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels Academic Article
Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial Academic Article
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer Academic Article
Low molecular weight heparin: a critical analysis of clinical trials. Academic Article
Low molecular weight heparin: laboratory properties and clinical evaluation. A review. Academic Article
Low molecular weight heparins Academic Article
Low molecular weight heparins and heparinoids Academic Article
Low molecular weight heparins in the treatment of unstable angina. Academic Article
Low molecular weight heparins: deep vein thrombosis prophylaxis in elective hip surgery and thrombotic stroke. Academic Article
Low-Molecular-Weight Heparin Academic Article
Low-Molecular-Weight Heparin Compared with Intravenous Unfractionated Heparin for Treatment of Pulmonary Embolism Academic Article
Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months Academic Article
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin Academic Article
Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction Academic Article
Low-Molecular-Weight Heparin for Pulmonary Embolism Academic Article
Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results Academic Article
Low-Molecular-Weight Heparin in Pediatric Patients Academic Article
Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism Academic Article
Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients Academic Article
Low-Molecular-Weight Heparin versus Unfractionated Heparin for Unstable Coronary Disease Academic Article
Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial Academic Article
Low-Molecular-Weight Heparin vs. Warfarin for Prophylaxis against Deep-Vein Thrombosis Academic Article
Low-Molecular-Weight Heparins Academic Article
Low-Molecular-Weight Heparins and Unstable Angina – Current Perspectives Academic Article
Low-Molecular-Weight Heparins in Acute Unstable Coronary Artery Disease – An Update Academic Article
Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes Academic Article
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery Academic Article
Low-molecular-weight Heparin for the treatment of venous thrombosis in patients with adenocarcinoma Academic Article
Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM) Academic Article
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants Academic Article
Low-molecular-weight heparin for the treatment of venous thromboembolism. Academic Article
Low-molecular-weight heparin in patients with chronic renal insufficiency Academic Article
Low-molecular-weight heparin in the treatment of pulmonary embolism. Academic Article
Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review Academic Article
Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial Academic Article
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis Academic Article
Low-molecular-weight heparin: from the bench to the orthopedic patient. Academic Article
Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis Academic Article
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review Academic Article
Low-molecular-weight heparins for the treatment of acute coronary syndrome and venous thromboembolism in patients with chronic renal insufficiency Academic Article
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Academic Article
Low‐molecular‐weight heparins and heparinoids Academic Article
Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy Academic Article
Management Of Venous Thromboembolism: Optimization By Clinical Trials Academic Article
Management of Deep Vein Thrombosis and Pulmonary Embolism Academic Article
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B. Academic Article
Management of iliofemoral thrombosis in a pregnant patient with heparin resistance Academic Article
Management of thromboembolic disease in cancer patients. Academic Article
Management of unstable angina and myocardial infarction Academic Article
Management of venous thromboembolism in cancer patients. Academic Article
Management strategies in unstable coronary artery disease-Current problems and future directions Academic Article
Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery Academic Article
Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer Academic Article
Measuring the anticoagulant effect of low molecular weight heparins in the critically ill. Academic Article
Mechanism of Action and Pharmacology of Unfractionated Heparin Academic Article
Mechanisms responsible for the failure of protamine  to inactivate low-molecular-weight heparin Academic Article
Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients Academic Article
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux Academic Article
Monitoring Unfractionated Heparin (UFH) therapy: Which Anti Factor Xa assay is appropriate? Academic Article
Mortality benefits of thromboprophylaxis Academic Article
Neutralization of Enoxaparine-lnduced Bleeding by Protamine Sulfate Academic Article
New Anticoagulant Strategies Academic Article
New Antithrombotic Drugs: Potential for Use in Oncology Academic Article
New Frontiers in the Management of Unstable Coronary Artery Disease Academic Article
New advances in the management of acute coronary syndromes: 4. Low-molecular-weight heparins. Academic Article
New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin Academic Article
Newer Anticoagulants in Critically Ill Patients Academic Article
Non-injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis Academic Article
Nonbleeding complications of unfractionated and low-molecular weight heparins. Academic Article
Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia Academic Article
Novel anticoagulant agents: introduction Academic Article
Optimal Anticoagulation for Pregnant Women with Mechanical Heart Valves Academic Article
Optimal timing of starting thromboprophylaxis for patients with acute spinal cord injury: A survey of Canadian spine surgeons Academic Article
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis Academic Article
Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours Academic Article
Overview of low molecular weight heparins and heparinoids: basic and clinical aspects. Academic Article
PREVENTION OF VENOUS THROMBO‐EMBOLISM Academic Article
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients Academic Article
PRE‐OPERATIVE FACTOR Xa–TFPI AND POST‐OPERATIVE VENOUS THROMBOSIS Academic Article
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma Academic Article
Parenteral Anticoagulants Academic Article
Parenteral Anticoagulants Academic Article
Parenteral anticoagulation for prolonging survival in patients with cancer who have no other indication for anticoagulation Academic Article
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
Parenteral anticoagulation in ambulatory patients with cancer Academic Article
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation Academic Article
Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review Academic Article
Patient values and preferences regarding VTE disease: a systematic review to inform American Society of Hematology guidelines Academic Article
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation Academic Article
Perioperative Bridging Therapy With Unfractionated Heparin or Low-Molecular-Weight Heparin in Patients With Mechanical Prosthetic Heart Valves on Long-Term Oral Anticoagulants (from the REGIMEN Registry) Academic Article
Perioperative Management of Oral Anticoagulation Academic Article
Perioperative Management of Warfarin Therapy: To Bridge or Not to Bridge, That Is the Question Academic Article
Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Academic Article
Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians Academic Article
Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation Academic Article
Periprocedural Management of Oral Anticoagulation Academic Article
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients Conference Paper
Pharmacologic tools to reduce bleeding in surgery. Academic Article
Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis Academic Article
Pharmacology of the low-molecular-weight heparins Academic Article
Plasma Thrombin Neutralization Assay: Pharmacokinetic Applications Academic Article
Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment? Academic Article
Post-discharge adherence with venous thromboembolism prophylaxis after orthopedic trauma: Results from a randomized controlled trial of aspirin versus low molecular weight heparin Academic Article
Postoperative Low-Molecular-Weight Heparin Bridging Is Associated with an Increase in Wound Hematoma Following Surgery for Pacemakers and Implantable Defibrillators Academic Article
Preclinical differentiation of low molecular weight heparins. Academic Article
Pregnancy-Associated Venous Thromboembolism: Prevention and Treatment Academic Article
Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery Academic Article
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE Academic Article
Preventing thrombophilia-related complications of pregnancy: an update Academic Article
Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Academic Article
Prevention and treatment of venous thromboembolism in the elderly patient. Academic Article
Prevention of Deep Vein Thrombosis after Elective Hip Surgery Academic Article
Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines Academic Article
Prevention of Venous Thromboembolism Among Hospitalized Medical Patients Academic Article
Prevention of Venous Thrombosis After Elective Hip Surgery Academic Article
Prevention of the Postthrombotic Syndrome with Anticoagulation: A Narrative Review Academic Article
Prevention of venous thromboembolism after major orthopedic surgery: summing up evidence about old and new antithrombotic agents Academic Article
Prevention of venous thromboembolism after surgery: A review of enoxaparin Academic Article
Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study Academic Article
Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire Academic Article
Prolonged Antithrombin Activity of Low-Molecular-Weight Heparins Academic Article
Prophylactic doses of enoxaparin and heparin inhibit prothrombin activation. Academic Article
Prophylactically Effective Doses of Enoxaparin and Heparin Inhibit Prothrombin Activation Academic Article
Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent Academic Article
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study Academic Article
Prophylaxis of Venous Thromboembolism in Stroke Patients Academic Article
Präoperative Bewertung des Blutungs- und Thromboseembolierisikos Academic Article
Pulmonary Embolism in Pregnancy Academic Article
Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism Academic Article
Randomized Trial of Warfarin Nomograms Academic Article
Randomized Trial of Warfarin Nomograms Academic Article
Randomized trial of warfarin nomograms. Academic Article
Rationale for development of low-molecular-weight heparins and their clinical potential in the prevention of postoperative venous thrombosis Conference Paper
Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins Academic Article
Recommendations on biosimilar low-molecular-weight heparins Academic Article
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis Academic Article
Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: A randomized trial Academic Article
Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty Academic Article
Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia Academic Article
Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management Academic Article
Reviparin in acute myocardial infarction. Academic Article
Risk of bleeding with vitamin K antagonists compared with low-molecular-weight heparin after orthopedic surgery: a rebuttal Academic Article
Rivaroxaban vs. low molecular weight heparin for the prevention of venous thromboembolism after hip or knee arthroplasty: a cohort study Academic Article
Routine heparin for patients with cancer? One answer, more questions Academic Article
Routine home treatment of deep vein thrombosis Academic Article
Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure: A Meta-analysis of Randomized Trials Academic Article
Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study. Academic Article
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence Academic Article
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Academic Article
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE Academic Article
Should vitamin K antagonist therapy be started simultaneously with parenteral anticoagulation Academic Article
Significant association with location of central venous line placement and risk of venous thrombosis in children Academic Article
Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST) Academic Article
So, Does Low-Molecular-Weight Heparin Cause Less Heparin-Induced Thrombocytopenia Than Unfractionated Heparin or Not? Academic Article
Standard and Low Molecular Weight Heparin Have no Effect on Tissue Plasminogen Activator Induced Plasma Clot Lysis or Fibrinogenolysis Academic Article
State of the Art-A Journey through the World of Antithrombotic Therapy Academic Article
Strategies and outcomes of periprocedural bridging therapy with low-molecular-weight heparin in patients with mechanical heart valves Academic Article
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the ‘Tinzaparin in Acute Ischaemic Stroke Trial’ (TAIST) Academic Article
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective Academic Article
Suboptimal Monitoring and Dosing of Unfractionated Heparin in Comparative Studies with Low-Molecular-Weight Heparin Academic Article
Successors to heparin: new antithrombotic agents. Academic Article
Survey of pharmacologic thromboprophylaxis in critically ill children* Academic Article
Symptomatic venous thromboembolism after orthognathic operations: An audit Academic Article
The Additive Effect of Low Molecular Weight Heparins on Thrombin Inhibition by Dermatan Sulfate Academic Article
The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells Academic Article
The Cost-Effectiveness of Extended-Duration Antithrombotic Prophylaxis After Total Hip Arthroplasty Academic Article
The Duration of Oral Anticoagulant Therapy after a Second Episode of Venous Thromboembolism Academic Article
The Effects of Standard and Low Molecular Weight Heparin on Bone Nodule Formation In Vitro Academic Article
The Efficacy and Safety of Heparin in Patients With Sepsis Academic Article
The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis Conference Paper
The Perioperative Management of Antithrombotic Therapy Academic Article
The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement Academic Article
The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome Academic Article
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients Academic Article
The comparison of the pharmacokinetics of a low molecular weight heparin in the newborn and adult pig Academic Article
The emerging role of low-molecular-weight heparin in cardiovascular medicine Academic Article
The low molecular weight heparin Enoxaparin inhibits the consumption of factor VII and prothrombin activation in vivo associated with elective knee replacement surgery Academic Article
The management of patients who require temporary reversal of vitamin K antagonists for surgery: a practical guide for clinicians Academic Article
The new heparins Academic Article
The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin. Academic Article
The risk and prevention of venous thromboembolism in the pregnant traveller Academic Article
The safety of antithrombotic therapy during pregnancy Academic Article
The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol Academic Article
The status of new anticoagulants Academic Article
The uses of heparin to treat burn injury. Academic Article
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 Academic Article
Therapy of unstable angina with the low molecular weight heparins Academic Article
Think of HIT When Thrombosis Follows Heparin Academic Article
Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis Academic Article
Thromboembolism in children with sarcoma Academic Article
Thromboembolism prevention in ischaemic stroke Academic Article
Thrombolysis and Adjunctive Therapy in Acute Myocardial Infarction Conference Paper
Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis Academic Article
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial Academic Article
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? Academic Article
Thromboprophylaxis after Knee Arthroscopy Academic Article
Thromboprophylaxis after knee arthroscopy does not decrease the risk of deep vein thrombosis: a network meta-analysis Academic Article
Thromboprophylaxis in Medical Patients – Why Not For All? Conference Paper
Thromboprophylaxis in Patients Receiving Chemotherapy Academic Article
Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin Academic Article
Thromboprophylaxis in medical–surgical critically ill patients Academic Article
Thromboprophylaxis in surgical patients. Academic Article
Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients Academic Article
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit Academic Article
Thromboprophylaxis practice patterns in two Western Australian teaching hospitals. Academic Article
Thromboprophylaxis using combined intermittent pneumatic compression and pharmacologic prophylaxis versus pharmacologic prophylaxis alone in critically ill patients: study protocol for a randomized controlled trial Academic Article
Thrombosis and cancer: implications beyond Trousseau Academic Article
Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial Academic Article
To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections Academic Article
Treatment and prophylaxis of venous thromboembolism during pregnancy Academic Article
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
Treatment of Venous Thromboembolism in Cancer Patients Academic Article
Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management Academic Article
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis Academic Article
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Academic Article
Unanswered questions in venous thromboembolism Academic Article
Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction Academic Article
Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis Academic Article
Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis Academic Article
Unstable angina. Academic Article
Unstable angina. Academic Article
Updates in thrombosis in pediatrics: where are we after 20 years? Academic Article
Urologic Surgery Academic Article
Use of Antithrombotic Agents During Pregnancy Academic Article
Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes Academic Article
Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions Academic Article
Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children Academic Article
Use of antithrombotic agents during pregnancy. Academic Article
Using low molecular weight heparin in special patient populations Academic Article
VTE Prophylaxis in Critically Ill Adults Academic Article
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014 Academic Article
Venous Thromboembolism in Hip Fracture Patients: A Subanalysis of the FAITH and HEALTH Trials Academic Article
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy Academic Article
Venous thromboembolism in critical illness in a community intensive care unit Academic Article
Venous thromboembolism in pregnancy: diagnosis, management and prevention Academic Article
Venous thromboembolism: diagnosis and management of deep venous thrombosis Academic Article
Venous thromboembolism: diagnosis and management of pulmonary embolism Academic Article
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism Academic Article
Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K Academic Article
Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more Academic Article
What is the role for antithrombotics in cancer care? Academic Article
Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? Academic Article
Women’s values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview study Academic Article
Women’s values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review Academic Article
Work-related effort thrombosis in a millwright: A case report Academic Article
[Congestive cardiomyopathy and left intraventricular thrombus as a manifestation of Churg-Strauss syndrome]. Academic Article
[Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]. Academic Article
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update]. Academic Article
“Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome Academic Article

Heparin, Low-Molecular-Weight Concept

Vocabulary Service

Overview

subject area of